Physician profile
Alan J Pitt
NPI 1659301950
$2,048.83
in general payments reported to CMS, 2019-2025
16 companies · $47.96 in 2025
The $47.96 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $153 · 2021: $504 · 2022: $621 · 2023: $340 · 2024: $229 · 2025: $47.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,239.67 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $183.69 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $109.29 | 2020-2024 | Ilumya |
| Janssen Biotech, INC. | $94.25 | 2022-2024 | Tremfya |
| Leo Pharma INC. | $82.82 | 2022-2024 | Adbry |
| Amgen INC. | $66.50 | 2019-2024 | Otezla |
| Dermavant Sciences, INC. | $56.02 | 2023-2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $40.70 | 2023 | |
| Ucb, INC. | $35.16 | 2023-2024 | Bimzelx |
| Pfizer INC. | $27.18 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.48 | 2022 | |
| Verrica Pharmaceuticals INC. | $22.01 | 2023 | Ycanth |
| Lilly USA, LLC | $20.78 | 2023 | Taltz, Olumiant |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.63 | 2023 | Cyltezo |
| Kyowa Kirin, INC. | $13.70 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Pitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.